IBSA USA
Alex Walker is a seasoned professional in the sales and dental hygiene fields, currently working as a Specialty Pharmaceutical Sales Representative at IBSA USA since February 2024. Prior experience includes serving as a Territory Sales Representative at Hiossen from October 2022 to February 2024, and working as a Registered Dental Hygienist at both Thompson Family Dental and Health Staff between July 2019 and June 2022. Additionally, Alex gained valuable experience as a Sales Associate and Team Member Trainer at Target from May 2016 to December 2019. Alex holds a Bachelor's degree in Dental Hygiene/Hygienist from the University of Missouri-Kansas City School of Dentistry and a Bachelor's degree in Human Development and Family Sciences from Oklahoma State University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.